跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gopra - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gopra
Approved
STANDARD
Gopra
Ahlcon Parenterals (India) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dbcdd988ef4c824a
Company
Ahlcon Parenterals (India) Limited
Type
Standard
Approval Details
Approval Id
dbcdd988ef4c824a
Drug Approval Philippines Name
Gopra
Product Name
Gopra
Registration Number
DRP-11882-03
Brand Name
Gopra
Generic Name
Salbutamol (as sulfate) + Ipratropium (as bromide)
Dosage Form
Solution for Inhalation
Dosage Strength
2.5 mg/500 mcg per 2.5 mL
Manufacturer
Ahlcon Parenterals (India) Limited
Importer
Medinova Pharmaceutical Inc
Distributor
Applied Pharmaceutical Distribution Inc.
Issuance Date
29 April 2024
Expiry Date
16 May 2027
Pharmacologic Category
Adrenergics in combination with anticholinergic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dbcdd988ef4c824a
Type
Standard
Back to Philippines FDA Approvals